ADC Therapeutics (ADCT) Asset Utilization Ratio (2021 - 2026)
ADC Therapeutics (ADCT) posted Asset Utilization Ratio of 0.26 for Q1 2026, up 2.55% sequentially from 0.25 in Q3 2025, and down 0.52% YoY from 0.26 in Q1 2025.
ADC Therapeutics (ADCT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.26 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | ADC Therapeutics | 152.38 Mn | -66.73 Mn | 17.14 Mn | 0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26 |
| Mar 31, 2026 | 0.26 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.26 |
| Mar 31, 2025 | 0.26 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.20 |
| Mar 31, 2024 | 0.21 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.27 |
| Mar 31, 2023 | 0.33 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.11 |
| Sep 30, 2021 | 0.03 |
| Jun 30, 2021 | 0.01 |